• ALung Technologies (Pittsburgh), developer of a lung replacement therapy, reported the appointment of Peter DeComo to the position of CEO effective Jan. 1. DeComo was formerly CEO of Renal Solutions. DeComo has served as the ALung chairman for the past six months. Additionally, former chairman of Respironics, Gerald McGinnis, has committed to provide up to $1.8 million in the form of convertible debt for bridge funding, to allow the company to complete necessary research and development of its Hemolung device, as it readies for 2009 clinical trials. Nick Kuhn, who has served as CEO of ALung since 2001 will assume the role of COO for ALung.

• Robert Bowen has been named VP and CFO of Abiomed (Danvers, Massachusetts), a provider of heart recovery and circulatory support products. Bowen previously was VP and CFO for GSI Group (Bedford, Massachusetts).

• ArthroCare (Austin, Texas) reported several senior management promotions, all effective immediately. James Pacek has been promoted to the position of senior VP, Strategic Business Units. Pacek previously served as VP and general manager, Interventional Therapies and also has experience in directing ArthroCare’s Sports Medicine business. Sten Dahlborg has been promoted to president, International. Dahlborg previously served as senior VP and GM, International Operations. Richard Rew II, has been promoted to senior VP, legal affairs. Rew previously served as VP, general counsel and secretary of Activant Solutions and as general counsel of Ezcorp. Michael Moehring has been promoted to VP and general, Spine Businesses. Moehring previously served as senior director, Sales and Marketing, Spine businesses. Brian Simmons has been promoted to the position of VP finance and chief accounting officer. Simmons joined ArthroCare in February 2007 and previously served as VP, Finance. ArthroCare develops minimally invasive surgical products.

• bioMérieux (Marcy L’Etoile, France) reported that Alexandre Mérieux has been appointed directeur général délégué. Stéphane Bancel continues to be responsible for all functions in his role as CEO and to chair the bioMérieux management committee. Mérieux has been a member of the bioMérieux board since 2004. He also will continue as corporate VP of Industrial Microbiology. bioMérieux is a diagnostics developer.

• LifeCare Holdings (Plano, Texas) reported that Greg Floyd will join the company in the role of senior VP of regional hospital operations for the 20-facility, long-term, acute care system. Floyd joins LifeCare from Select Medical, where he has held positions as a regional VP, as well as VP/CEO of Select Specialty Hospital. Floyd has also held CEO positions in several other Select Hospitals, and clinical positions at Doctors Health Care Center, a long-term care center, and Zale Lipshy University Hospital, an acute care teaching hospital. LifeCare operates 20 long-term acute care hospitals in 10 states.